STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 74 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $786,000 | -13.9% | 61,139 | -36.4% | 0.00% | 0.0% |
| Q4 2018 | $913,000 | -45.8% | 96,116 | -5.3% | 0.00% | 0.0% |
| Q3 2018 | $1,684,000 | +100.2% | 101,458 | +93.6% | 0.00% | 0.0% |
| Q2 2018 | $841,000 | -38.0% | 52,399 | -40.9% | 0.00% | 0.0% |
| Q1 2018 | $1,357,000 | +72.4% | 88,679 | +75.8% | 0.00% | 0.0% |
| Q4 2017 | $787,000 | +31.6% | 50,442 | -6.4% | 0.00% | – |
| Q3 2017 | $598,000 | +13.9% | 53,900 | -5.5% | 0.00% | – |
| Q2 2017 | $525,000 | -1.3% | 57,062 | -8.3% | 0.00% | – |
| Q1 2017 | $532,000 | -8.4% | 62,199 | +14.5% | 0.00% | – |
| Q4 2016 | $581,000 | -17.1% | 54,311 | -16.1% | 0.00% | – |
| Q3 2016 | $701,000 | +60.8% | 64,768 | +0.5% | 0.00% | – |
| Q2 2016 | $436,000 | +78.0% | 64,450 | +22.4% | 0.00% | – |
| Q1 2016 | $245,000 | -36.0% | 52,643 | -13.2% | 0.00% | – |
| Q4 2015 | $383,000 | -42.2% | 60,629 | -19.2% | 0.00% | -100.0% |
| Q3 2015 | $663,000 | -25.0% | 75,069 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $884,000 | +4.4% | 75,069 | +28.3% | 0.00% | 0.0% |
| Q1 2015 | $847,000 | +12.5% | 58,508 | +32.6% | 0.00% | 0.0% |
| Q4 2014 | $753,000 | +37.2% | 44,115 | +0.0% | 0.00% | – |
| Q3 2014 | $549,000 | -20.5% | 44,098 | -6.3% | 0.00% | – |
| Q2 2014 | $691,000 | -17.6% | 47,081 | +14.2% | 0.00% | -100.0% |
| Q1 2014 | $839,000 | +0.6% | 41,209 | -3.1% | 0.00% | 0.0% |
| Q4 2013 | $834,000 | -50.6% | 42,539 | +14.2% | 0.00% | 0.0% |
| Q3 2013 | $1,687,000 | +48.0% | 37,239 | -22.1% | 0.00% | 0.0% |
| Q2 2013 | $1,140,000 | – | 47,803 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|